Search - tctmd.com

Displaying 661 - 680 of 692

Sort: Relevancy | Date

Presentation TCT 2013

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Presenter: Lisette Okkels Jensen

October 28, 2013

Presentation TCT 2013

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

Presenter: Peter Smits

October 28, 2013

Presentation TCT 2013

Yes: Clinical Trials Wwll Show Fewer Early and Late Events!

Presenter: Didier Carri?

October 27, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2013

The BioMime Stent and Merit Clinical Trials

Presenter: Martin Leon

October 27, 2013

Presentation TCT 2013

Moving Forward: The Dawn of Patient-Centered Clinical Trials and Translational Tools

Presenter: Bray Patrick-Lake

October 27, 2013

Presentation TCT 2013

How to be a Key Enroller in Clinical Trials: Bringing Your Colleagues Together

Presenter: Nicholas Lembo

October 27, 2013

Presentation Scripps 2013

Show Me the Data: Key Clinical Trials in 2012-2013

Presenter: David E. Kandzari

October 03, 2013

Presentation SOLACI 2013

Clinical Trials Phases

Presenter: Alejandra Guerchicoff

July 24, 2013

Presentation TVT 2013

Unique Challenges of Supporting TAVR Clinical Trials

Presenter: Elizabeth Walsh

June 14, 2013

Presentation TCT 2013

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati

January 31, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

Presentation AHA 2012

Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction- Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

Presenter: Saurav Chatterjee

November 04, 2012

Presentation TCT 2012

Impact of FDASIA on Clinical Trials

Presenter: Ashley Boam

October 25, 2012

Presentation TCT 2012

Completed and Ongoing Clinical Trials

Presenter: Laura Mauri

October 25, 2012

Presentation TCT 2012

Transcatheter Pulmonary Valve Replacement: Clinical Trials and Real-world Experiences

Presenter: William Hellenbrand

October 25, 2012

Presentation TCT 2012

The Misinterpretation of Clinical Trials: Common Errors and Case Examples

Presenter: Sanjay Kaul

October 25, 2012

Presentation TCT 2012

The Dos and Don'ts of Initiating Prospective Randomized Clinical Trials

Presenter: Adnan Kastrati

October 25, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Advertisement

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

Yes: Clinical Trials Wwll Show Fewer Early and Late Events!

The Spectrum of Current and Future Renal Denervation Clinical Trials

The BioMime Stent and Merit Clinical Trials

Moving Forward: The Dawn of Patient-Centered Clinical Trials and Translational Tools

How to be a Key Enroller in Clinical Trials: Bringing Your Colleagues Together

Show Me the Data: Key Clinical Trials in 2012-2013

Clinical Trials Phases

Unique Challenges of Supporting TAVR Clinical Trials

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction- Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

Impact of FDASIA on Clinical Trials

Completed and Ongoing Clinical Trials

Transcatheter Pulmonary Valve Replacement: Clinical Trials and Real-world Experiences

The Misinterpretation of Clinical Trials: Common Errors and Case Examples

The Dos and Don'ts of Initiating Prospective Randomized Clinical Trials

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content